Concepedia

Publication | Open Access

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer

DOIFull Paper Access

41

Citations

38

References

2009

Year

J.S.P. Yuen, Erdem Akkaya, Yong Wang, Megumi Takiguchi, S. A. PEAK, Mark Sullivan, Andrew Protheroe, Valentine M. Macaulay
Molecular Cancer Therapeutics

Abstract

These data validate IGF1R as a therapeutic target in CC-RCC, and support the evaluation of IGF1R-inhibitory drugs in patients with renal cancer.

References

YearCitations

Page 1